newsfilter
← Latest News
GlobeNewswire·

Caladrius Biosciences Announces Participation in Upcoming Conferences in October 2021

BASKING RIDGE, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) ("Caladrius" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease,